Guohuan Yang - Publications

Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors after transplant: A prospective pilot trial.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 11, 2025

Vaccines' New Era-RNA Vaccine.

Journal: Viruses

Published: July 24, 2023

Prospects for Nerve Regeneration and Gene Therapy in the Treatment of Traumatic Brain Injury.

Journal: Journal of molecular neuroscience : MN

Published: May 26, 2023

The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangiocarcinoma as Second-Line and Successive Treatment: A Real-World Study.

Journal: Canadian journal of gastroenterology & hepatology

Published: May 30, 2022

LINC00355 triggers malignant progression of hepatocellular carcinoma via the sponge effect on miR-217-5p with the involvement of the Wnt/β-catenin signaling.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: November 11, 2021

Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 05, 2017

GacS/GacA activates pyoluteorin biosynthesis through Gac/Rsm-RsmE cascade and RsmA/RsmE-driven feedback loop in Pseudomonas protegens H78.

Journal: Molecular microbiology

Published: July 11, 2017

Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 23, 2011